Centogene B V (CNTG)

NASDAQ
1.250
+0.030(+2.46%)
  • Volume:
    5
  • Day's Range:
    1.250 - 1.250
  • 52 wk Range:
    1.190 - 11.090

CNTG Overview

Prev. Close
1.2
Day's Range
1.25-1.25
Revenue
152.58M
Open
1.25
52 wk Range
1.19-11.09
EPS
-2.14
Volume
5
Market Cap
33.85M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
21,157
P/E Ratio
-1.02
Beta
-0.954
1-Year Change
-88.68%
Shares Outstanding
27,081,557
Next Earnings Date
Dec 21, 2022
What is your sentiment on Centogene?
or
Vote to see community's results!

Centogene B V News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Centogene B V Analysis

Centogene B V Company Profile

Centogene B V Company Profile

Employees
808

Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing. The company develops rare disease platform, a data and biological repository, which includes epidemiologic, phenotypic, and heterogenetic data that enhances methods for identifying and monitoring rare hereditary diseases and provide solutions that accelerate the development of orphan drugs. It provides various services, including target discovery, early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring; and genetic sequencing and diagnostics services to physicians, laboratories, or hospitals directly or through distributors. The company also offers COVID-19 testing solutions, including PCR and antigen testing services. It has collaboration and license agreements with Shire International GmbH, Pfizer Inc., Dr. Bauer Laboratoriums GmbH, Fraport AG, Takeda Pharmaceutical Company Limited, and Twist Bioscience Corporation. Centogene N.V. was founded in 2006 and is headquartered in Rostock, Germany.

Read More

Analyst Price Target

Average10.000 (+700.00% Upside)
High10
Low10
Price1.25
No. of Analysts1
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellSellStrong SellStrong Sell
Technical IndicatorsNeutralNeutralStrong SellStrong SellStrong Sell
SummaryNeutralNeutralStrong SellStrong SellStrong Sell
  • https://seekingalpha.com/pr/17945745-centogene-and-molecular-health-announce-exclusive-collaboration-aim-to-transform-development
    0
    • https://www.globenewswire.com/news-release/2020/07/23/2066318/0/en/CENTOGENE-Announces-Convenient-At-Home-Coronavirus-Test-Solution-Now-Available-in-Germany-on-Online-Marketplace.html
      0